|
1
|
Zhou GJ, Zhang Y, Wang J, Guo JH, Ni J,
Zhong ZM, Wang LQ, Dang YJ, Dai JF and Yu L: Cloning and
characterization of a novel human RNA binding protein gene PNO1.
DNA Seq. 15:219–224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li XY, Luo QF, Li J, Wei CK, Kong XJ,
Zhang JF and Fang L: Clinical significance of NOB1 expression in
breast infiltrating ductal carcinoma. Int J Clin Exp Pathol.
6:2137–2144. 2013.PubMed/NCBI
|
|
4
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu K, Gu MM, Chen HL and You QS: NOB1 in
non-small-cell lung cancer: Expression profile and clinical
significance. Pathol Oncol Res. 20:461–466. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu G, Shen D, Jiao L and Sun Y: Nin one
binding protein expression as a prognostic marker in prostate
carcinoma. Clin Transl Oncol. 16:843–847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao X, Wang J, Bai W, Ji W and Wang L:
NOB1 silencing inhibits the growth and metastasis of laryngeal
cancer cells through the regulation of JNK signaling pathway. Oncol
Rep. 35:3313–3320. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman MA and Carter SK: The therapy of
osteogenic sarcoma: Current status and thoughts for the future. J
Surg Oncol. 4:482–510. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kawahara M, Takahashi Y, Takazawa K,
Tsuchiya H, Tomita K, Yokogawa K and Miyamoto K: Caffeine
dose-dependently potentiates the antitumor effect of cisplatin on
osteosarcomas. Anticancer Res. 28(3A): 1–1685. 2008.PubMed/NCBI
|
|
11
|
Reinheckel T, Ullrich O, Sitte N and Grune
T: Differential impairment of 20S and 26S proteasome activities in
human hematopoietic K562 cells during oxidative stress. Arch
Biochem Biophys. 38:65–68. 2000. View Article : Google Scholar
|
|
12
|
Tone Y1 and Toh E: A Nob1p is required for
biogenesis of the 26S proteasome and degraded upon its maturation
in Saccharomyces cerevisiae. Genes Dev. 16:3142–3157. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lamanna AC and Karbstein K: Nob1 binds the
single-stranded cleavage site D at the 3′-end of 18S rRNA with its
PIN domain. Proc Natl Acad Sci USA. 106:pp. 14259–14264. 2009;
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fatica A, Oeffinger M, Dlakić M and
Tollervey D: Nob1p is required for cleavage of the 3′ end of 18S
rRNA. Mol Cell Biol. 23:1798–1807. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fatica A, Tollervey D and Dlakić M: PIN
domain of Nob1p is required for D-site cleavage in 20S pre-rRNA.
RNA. 10:1698–1701. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Dong BF, Wang PS, Ren PY, Xue S,
Zhang XΝ, Han Z and Chen G: Silencing NOB1 enhances doxorubicin
antitumor activity of the papillary thyroid carcinoma in vitro and
in vivo. Oncol Rep. 33:1551–1559. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Meng W, Wang PS, Liu J, Xue S, Wang GM,
Meng XY and Chen G: Adenovirus-mediated siRNA targeting NOB1
inhibits tumor growth and enhances radiosensitivity of human
papillary thyroid carcinoma in vitro and in vivo. Oncol Rep.
32:2411–2420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He XW, Feng T, Yin QL, Jian YW and Liu T:
NOB1 is essential for the survival of RKO colorectal cancer cells.
World J Gastroenterol. 21:868–877. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Downregulation of NOB1 suppresses the proliferation and tumor
growth of non-small cell lung cancer in vitro and in vivo. Oncol
Rep. 31:1271–1276. 2014. View Article : Google Scholar : PubMed/NCBI
|
